Publications
Neutral sphingomyelinase 2 inhibitors based on the pyrazolo[1,5-a] scaffold. European Journal of Medicinal Chemistry 2023, 259 (November).
Piperazine-Modified Ketoconazole Derivatives Show Increased Activity against Fungal and Trypanosomatid Pathogens. ChemMedChem 2022, 17 (21), nestránkováno.